Patheon
Generated 6/6/2026
Executive Summary
Patheon, operating as Patheon pharma services under Thermo Fisher Scientific, is a global contract development and manufacturing organization (CDMO) headquartered in Lyon, France. It provides end-to-end services for the pharmaceutical, biotech, and life sciences industries, covering drug development, clinical trial logistics, and commercial manufacturing. Patheon supports a wide range of modalities including small molecules, biologics, and advanced therapies such as viral vectors and mRNA. As a subsidiary of Thermo Fisher Scientific, Patheon benefits from significant resources and a broad client base, positioning it as a key player in the CDMO space. The company's valuation is estimated at over $182 billion, reflecting its scale and strategic importance within the parent organization. Patheon continues to invest in capacity expansions and new technologies to meet growing demand for outsourced pharmaceutical manufacturing.
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)